For decades, sickle cell disease has been managed, endured, and survived — but rarely spoken of in terms of cure. That narrative shifted in New York this month, where a 21-year-old patient became the first in the state to receive a one-time gene therapy that clinicians say has left him free of sickle cell symptoms. Administered at Cohen Children’s Medical Center, the treatment represents more than a clinical milestone; it signals a possible turning point for a condition that disproportionately affects Black communities and has long been underfunded, understudied, and underserved. While questions of access and cost remain, the moment marks a powerful glimpse of what medical equity could begin to look like.
Source: @afrocentricfilmscollaborative
